Nupur Mittal to Humans
This is a "connection" page, showing publications Nupur Mittal has written about Humans.
Connection Strength
0.442
-
Shared barriers and facilitators to enrollment of adolescents and young adults on cancer clinical trials. Sci Rep. 2022 03 09; 12(1):3875.
Score: 0.043
-
Barriers to Pediatric Oncologist Enrollment of Adolescents and Young Adults on a Cross-Network National Clinical Trials Network Supportive Care Cancer Clinical Trial. J Adolesc Young Adult Oncol. 2022 02; 11(1):117-121.
Score: 0.041
-
T-cell large granular lymphocytic leukemia successfully treated with oral cyclosporine in a child: Case report and review of literature. Pediatr Blood Cancer. 2020 12; 67(12):e28487.
Score: 0.038
-
A critical role of epigenetic inactivation of miR-9 in EVI1high pediatric AML. Mol Cancer. 2019 02 27; 18(1):30.
Score: 0.035
-
A Tri-Institutional Approach to Address Disparities in Children's Oncology Group Clinical Trial Accrual for Adolescents and Young Adults and Underrepresented Minorities. J Adolesc Young Adult Oncol. 2019 06; 8(3):227-235.
Score: 0.035
-
Steroid Responsive Atypical Hemolytic Uremic Syndrome Triggered by Influenza B Infection. J Pediatr Hematol Oncol. 2019 01; 41(1):e63-e67.
Score: 0.034
-
Severe nondominant hereditary spherocytosis in an infant with coinheritance of three rare alpha-spectrin gene defects. Pediatr Blood Cancer. 2019 01; 66(1):e27480.
Score: 0.034
-
Primary Orbital Histiocytic Sarcoma in a Child Successfully Treated With Multiagent Chemotherapy. J Pediatr Hematol Oncol. 2016 11; 38(8):653-657.
Score: 0.030
-
A unique description of stage IV extranodal marginal zone lymphoma (EMZL) in an adolescent associated with gamma heavy chain disease. Pediatr Blood Cancer. 2015 May; 62(5):905-8.
Score: 0.026
-
Insights into the genetic basis of familal hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2014 Jun; 61(6):962-3.
Score: 0.025
-
Metastatic and recurrent bone primary bone cancers. Curr Probl Cancer. 2013 Jul-Aug; 37(4):215-24.
Score: 0.024
-
Children's Oncology Group 2023 blueprint for research: Adolescent and young adult oncology. Pediatr Blood Cancer. 2023 09; 70 Suppl 6:e30564.
Score: 0.012
-
Adolescent and young adult cancers: unmet needs and closing the gaps. Curr Opin Pediatr. 2023 02 01; 35(1):84-90.
Score: 0.011
-
Creation of a quality improvement collaborative to address adolescent and young adult cancer clinical trial enrollment: ATAQI (AYA trial access quality initiative). Curr Probl Cancer. 2023 Dec; 47(6):100898.
Score: 0.011
-
Use of Communication Technology to Improve Clinical Trial Participation in Adolescents and Young Adults With Cancer: Consensus Statement From the Children's Oncology Group Adolescent and Young Adult Responsible Investigator Network. JCO Oncol Pract. 2022 03; 18(3):224-231.
Score: 0.011
-
The Children's Oncology Group Adolescent and Young Adult Responsible Investigator Network: A New Model for Addressing Site-Level Factors Impacting Clinical Trial Enrollment. J Adolesc Young Adult Oncol. 2020 08; 9(4):522-527.
Score: 0.009
-
Aberrant splicing contributes to severe a-spectrin-linked congenital hemolytic anemia. J Clin Invest. 2019 04 30; 129(7):2878-2887.
Score: 0.009
-
The Moonshot Initiative: Randomized, Controlled Trials, and Its Impact in Pediatric Oncology. J Pediatr Hematol Oncol. 2018 07; 40(5):413-414.
Score: 0.008
-
?-Catenin Is a Candidate Therapeutic Target for Myeloid Neoplasms with del(5q). Cancer Res. 2017 08 01; 77(15):4116-4126.
Score: 0.008